#cancer research

Here’s how the American Cancer Society and its advocacy affiliate support eight priorities of the National Cancer Plan.

Dana-Farber breast cancer researchers performed genomic testing, yielding findings may help personalize treatment in the future.

Antonio Jimeno, MD, PhD, led research studying a cell squeezing process used to treat a subtype of HPV16-driven head and neck cancer.

Cancer Health editor Trent Straube introduces the spring 2023 issue, including articles on treatments, exercise, clinical trials and more.

Clinical trials are scientific studies of experimental treatments. Here’s how to find one that might be right for you.

Check out these promising breast cancer studies.

Dana-Farber researchers explore CAR-T therapy and next generation immunotherapy to target colorectal cancer.

Fred Hutch study suggests certain immune cells are the source of antibodies that attack donated organs.

Scientists from the Leukemia & Lymphoma Society participated in a career development program for college members. Here’s what they said.

The Dana-Farber led ALPINE trial looked at the drug in relapsed chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

Black patients with ovarian cancer were less likely than their white counterparts to be treated according to NCCN guidelines.

Tests prevented relapse and limited graft-vs.-host disease (GVHD) in laboratory models of leukemia and multiple myeloma.

Study results support the need for research into the value of monitoring these breast cancer patients with brain imaging tests.

Joining First Lady Jill Biden, R&B icon Mary J. Blige spoke about racial disparities in cancer prevention and treatment.

University of California San Francisco hosted First Lady Jill Biden to speak about the Cancer Moonshot and breast cancer research.

The patient-driven Metastatic Prostate Cancer Research Project releases its first report.